Mediation of arachidonic acid metabolite(s) produced by endothelial cytochrome P-450 3A4 in monkey arterial relaxation

Hypertension Research

Volumn 26, Issue 3, 2003, Pages 237-243

  Ayajiki, Kazuhide ^d   Fujioka, Hideyuki ^d   Toda, Noboru ^d   Okada, Shigeru ^a   Minamiyama, Yukiko ^b   Imaoka, Susumu ^b   Funae, Yoshihiko ^b   Watanabe, Shuji ^c   Nakamura, Akio ^c   Okamura, Tomio ^d  

^a OKAYAMA UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NIPPON SHINYAKU CO LTD   (Japan)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Acetylcholine; Arachidonic acid metabolite(s); Endothelium dependent relaxation; Monkey artery; P 450 3A4 antibody

Indexed keywords

ACETYLCHOLINE; APAMIN; ARACHIDONIC ACID; CATALASE; CHARYBDOTOXIN; CYTOCHROME P450 3A4; ENDOTHELIUM DERIVED RELAXING FACTOR; EPOXYICOSATRIENOIC ACID; GLYCYRRHETINIC ACID DERIVATIVE; HYDROGEN PEROXIDE; INDOMETACIN; KETOCONAZOLE; MEPACRINE; N(G) NITROARGININE; NITRIC OXIDE; OXYGEN; PHOSPHOLIPASE A2 INHIBITOR; POTASSIUM CHANNEL; POTASSIUM ION; PROSTANOID; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GAP JUNCTION; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; LIVER MICROSOME; MALE; METABOLITE; MONKEY; MUSCLE ISOMETRIC CONTRACTION; MUSCLE RELAXATION; NONHUMAN; SENSITIVITY ANALYSIS; SMOOTH MUSCLE FIBER; TONGUE;

ACETYLCHOLINE; ANIMALS; ARACHIDONIC ACID; BIOLOGICAL ASSAY; CARDIOVASCULAR AGENTS; CATALYSIS; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INDOMETHACIN; MACACA; MALE; NITROARGININE; VASODILATION; VASODILATOR AGENTS;

EID: 1642423551     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.237     Document Type: Article

References (28)

1. Mombouli J-V, Vanhoutte PM: Endothelium-derived hyperpolarizing factor(s): updating the unknown. Trends Pharmacol Sci 1997; 18: 252-256.
2. Campbell WB, Gebremedhin D, Pratt PF, Harder DR: Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996; 78: 415-423.
3. Gebremedhin D, Harder DR, Pratt PF, Campbell WB: Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: role of a cytochrome P450 metabolite. J Vasc Res 1998; 35: 274-284.
4. Fisslthaler B, Popp R, Kiss L, et al: Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 1999; 401: 493-497.
5. Hecker M, Bara AT, Bauersachs J, Busse R: Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol (Lond) 1994; 481: 407-414.
6. + channels. Circ Res 1998; 83: 501-507.
7. 2-independent vasorelaxation and the cytochrome P450 pathway in rabbit carotid artery. Br J Pharmacol 1997; 120: 695-701.
8. + channel opening substance in monkey lingual artery. Br J Pharmacol 1999; 128: 802-808.
9. Capdevila JH, Karara A, Waxman DJ, Martin MV, Falck JR, Guenguerich FP: Cytochrome P450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase. J Biol Chem 1990; 265: 10865-10871.
10. Chataigneau T, Félétou M, Duhault J, Vanhoutte PM: Epoxyeicosatrienoic acids, potassium channel blockers and endothelium-dependent hyperpolarization in the guinea-pig carotid artery. Br J Pharmacol 1998; 123: 574-580.
11. Eckman DM, Hopkins N, McBride C, Keef KD: Endothelium-dependent relaxation and hyperpolarization in guinea-pig coronary artery: role of epoxyeicosatrienoic acid. Br J Pharmacol 1998; 124: 181-189.
12. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998; 396: 269-272.
13. Matoba T, Shimokawa H, Nakashima M, et al: Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 2000; 106: 1521-1530.
14. Matoba T, Shimokawa H, Kubota H, et al: Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 2002; 290: 909-913.
15. Campbell WB, Harder DR: Endothelium-derived hyperpolarizing factors and vascular cytochrome P-450 metabolites of arachidonic acid in the regulation of tone. Circ Res 1998; 84: 484-488.
16. Hecker M: Endothelium-derived hyperpolarizing factor-fact or fiction? News Physiol Sci 2000; 15: 1-5.
17. Triggle CR, Dong H, Waldron GJ, Cole WC: Endothelium-derived hyperpolarization factors(s); species and tissue heterogeneity. Clin Exp Pharmacol Physiol 1999; 26: 176-179.
18. Chaytor AT, Evans WH, Griffith TM: Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries. J Physiol (Lond) 1998; 508: 561-573.
19. 2. Circ Res 1999; 84: 53-63.
20. Kohagura K, Arima S, Endo Y, et al: Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arterioles. Hypertens Res 2001; 24: 551-557.
21. Fujioka H, Ayajiki K, Shinozaki K, Toda N, Okamura T: Mechanisms underlying endothelium-dependent, nitric oxide- and prostanoid-independent relaxation in monkey and dog coronary arteries. Naunyn Schmiedebergs Arch Pharmacol 2002; 366: 488-495.
22. Imaoka S, Yamada T, Hiroi T, et al: Multiple forms of human P450 expressed in Saccharomyces cerevisiae: systematic characterization and comparison with those of the rat. Biochem Pharmacol 1996; 51: 1041-1050.
23. Maurice M, Pichard L, Daujat M, et al: Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB J 1992; 6: 752-758.
24. Mancy A, Dijols S, Poli S, Guengerich P, Mansuy D: Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9. Biochemistry 1996; 35: 16205-16212.
25. Schwartzman M, Carroll MA, Ibraham NG, Ferreri NR, Songu-Mize E, McGiff JC: Renal arachidonic acid metabolism: the third pathway. Hypertension 1985; 7: I136-I144.
26. Minamiyama Y, Tamemura S, Akiyama T, et al: Isoforms of cytochrome P450 on organic nitrate-derived nitric oxide release in human vessels. FEBS Lett 1999; 452: 165-169.
27. Quilley J, McGiff JC: Is EDHF an epoxyeicosatrienoic acid? Trends Pharmacol Sci 2000; 21: 121-124.
28. Fulton D, McGiff JC, Quilley J: Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart. J Pharmacol Exp Ther 1998; 287: 497-503.